Q1 2018 Holdings
Filed 2018-05-10 | 108 holdings | $55.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $17.8M | 65,000 | 31.9% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $10.7M | 339,367 | 19.2% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $7.6M | 1,009,131 | 13.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $6.2M | 95,474 | 11.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.1M | 180,000 | 9.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.7M | 321,430 | 6.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.0M | 270,000 | 5.4% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $1.0M | 3,329 | 1.9% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $65.8K | 750,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $31.6K | 580,000 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $29.4K | 196,500 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $28.5K | 319,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $27.8K | 1,845,704 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $23.6K | 574,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $20.9K | 590,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $19.5K | 500,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $18.4K | 248,997 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $14.3K | 41,500 | 0.0% |
| Powershares QQQ TrustPut | UNIT SER 1 | 73935A104 | $12.8K | 80,000 | 0.0% |
| Innovate Biopharmaceuticls I | COM PAR | 45782F105 | $12.3K | 980,502 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $11.1K | 1,030,000 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $10.1K | 60,000 | 0.0% |
| Obseva SA | COM | H5861P103 | $10.1K | 745,197 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $9.1K | 82,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $8.9K | 168,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $8.0K | 335,500 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $7.7K | 260,000 | 0.0% |
| Mellanox Technologies LTD | SHS | M51363113 | $7.3K | 100,279 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $7.0K | 480,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.0K | 1,592,416 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.6K | 405,000 | 0.0% |
| Portola Pharmaceuticals IncCall | COM | 737010108 | $6.5K | 200,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.5K | 2,264,136 | 0.0% |
| Medicinova Inc(MNOV) | COM NEW | 58468P206 | $6.4K | 630,838 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $6.4K | 67,758 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $6.3K | 1,490,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.2K | 330,000 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $6.1K | 66,850 | 0.0% |
| Tesaro Inc | COM | 881569107 | $6.1K | 106,175 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.7K | 302,275 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.5K | 800,000 | 0.0% |
| Flex LTD(FLEX) | ORD | Y2573F102 | $5.0K | 307,839 | 0.0% |
| Delek US Hldgs Inc New(DK) | COM | 24665A103 | $5.0K | 122,284 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $5.0K | 4,792 | 0.0% |
| Retrophin Inc | COM | 761299106 | $4.9K | 220,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $4.8K | 775,000 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $4.8K | 40,401 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $4.7K | 475,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $4.6K | 225,000 | 0.0% |
| Allena Pharmaceuticals Inc(ALNAEUR) | COM | 018119107 | $4.5K | 410,199 | 0.0% |